Role of palliative radiotherapy in the management of mural cardiac metastases: who, when and how to treat? A case series of 10 patients

Cancer Med. 2016 Jun;5(6):989-96. doi: 10.1002/cam4.619. Epub 2016 Feb 16.

Abstract

Cardiac metastases (CM), although a rare manifestation of metastatic cancer, are increasing in incidence with the improved prognosis and increased longevity of many patients with cancer. This condition may be life-threatening, especially for bulky rapidly growing tumors. Such cancer presentations may be amenable to palliative radiotherapy to improve symptoms and to prevent further cardiac function decline. Here, we report on our experience with 10 patients with mural CM who received radiotherapy (RT) to the heart with palliative intent. The radiation treatment was given in different clinical situations using different dose and fractionation, and with a variety of outcomes. Palliative RT was a reasonably effective treatment, leading to good radiographic response in five patients who were evaluable for radiologic response. The mean duration of response in responding patients was 6.3 months (range: 3-11 months). This report describing clinical dilemmas around CM radiation therapy summarizes the previous experiences with radiation in treatment of CM and may assist in the considerations of palliative treatment for these patients.

Keywords: Heart; heart neoplasms; neoplasm metastasis; palliative medicine; radiotherapy.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Aged
  • Combined Modality Therapy
  • Disease Management
  • Disease Progression
  • Dose Fractionation, Radiation
  • Female
  • Heart Neoplasms / radiotherapy*
  • Heart Neoplasms / secondary*
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Palliative Care*
  • Radiotherapy Dosage
  • Treatment Outcome